We are live on
!
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$268M
1-Year Est. Return
158.98%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
92.95%
Top 10 Holdings %
Top 10 Hldgs %
42.01%
Holding
143
New
143
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Humana
HUM
|
+$10.2M |
| 2 |
DaVita
DVA
|
+$6.77M |
| 3 |
UnitedHealth
UNH
|
+$6.72M |
| 4 |
Pennant Group
PNTG
|
+$5.2M |
| 5 |
Cardinal Health
CAH
|
+$3.95M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 67.79% |
| 2 | Financials | 23.65% |
| 3 | Energy | 1.95% |
| 4 | Materials | 1.84% |
| 5 | Consumer Discretionary | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Relay Therapeutics
RLAY
$4.34B
| $652K | 0.54% |
+145,828
| New | +$794K |
|
52
Arcus Biosciences
RCUS
$3.44B
| $648K | 0.54% |
+50,213
| New | +$820K |
|
|
CNTA
53
DELISTED
Centessa Pharmaceuticals
CNTA
| $638K | 0.53% |
+37,701
| New | +$625K |
|
54
Cogent Biosciences
COGT
$6.68B
| $630K | 0.52% |
+67,617
| New | +$674K |
|
|
COOP
55
DELISTED
Mr. Cooper
COOP
| $581K | 0.48% |
+5,593
| New | +$532K |
|
56
Crinetics Pharmaceuticals
CRNX
$8.88B
| $531K | 0.44% |
+13,184
| New | +$738K |
|
57
Scholar Rock
SRRK
$6.33B
| $529K | 0.44% |
+13,103
| New | +$427K |
|
58
SmartFinancial
SMBK
$823M
| $526K | 0.44% |
+14,912
| New | +$493K |
|
59
CVB Financial
CVBF
$4.03B
| $518K | 0.43% |
+24,853
| New | +$526K |
|
60
KraneShares CSI China Internet ETF
KWEB
$5.32B
| $514K | 0.43% |
+16,440
| New | +$528K |
|
61
Viridian Therapeutics
VRDN
$1.99B
| $489K | 0.41% |
+25,237
| New | +$549K |
|
|
VBNK
62
VersaBank
VBNK
$681M
| $473K | 0.39% |
+34,178
| New | +$525K |
|
63
Edgewise Therapeutics
EWTX
$4.28B
| $465K | 0.39% |
+16,593
| New | +$528K |
|
64
Towne Bank
TOWN
$3.34B
| $444K | 0.37% |
+12,426
| New | +$432K |
|
65
Synchrony
SYF
$24.8B
| $429K | 0.36% |
+6,214
| New | +$380K |
|
66
Replimune Group
REPL
$859M
| $407K | 0.34% |
+29,103
| New | +$354K |
|
|
SAGE
67
DELISTED
Sage Therapeutics
SAGE
| $389K | 0.32% |
+53,721
| New | +$328K |
|
68
East-West Bancorp
EWBC
$18.4B
| $384K | 0.32% |
+3,727
| New | +$366K |
|
69
Nuvalent
NUVL
| $381K | 0.32% |
+4,435
| New | +$414K |
|
70
UWM Holdings
UWMC
$685M
| $375K | 0.31% |
+62,131
| New | +$404K |
|
71
Webster Financial
WBS
$12.3B
| $374K | 0.31% |
+6,211
| New | +$341K |
|
|
KALV
72
DELISTED
KalVista Pharmaceuticals
KALV
| $374K | 0.31% |
+41,952
| New | +$434K |
|
73
PUT
Keros Therapeutics
KROS
$211M
| $360K | 0.3% |
+153
| New | +$7.95K |
|
74
Pfizer
PFE
$143B
| $359K | 0.3% |
+13,530
| New | +$367K |
|
75
VistaGen Therapeutics
VTGN
$9.4M
| $352K | 0.29% |
+121,651
| New | +$342K |
|
Similar funds
VC
AL
FC
NF
PF
UI
SSWM
AC
Persistent Asset Partners's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Persistent Asset Partners, which disclosed 143 positions worth $121M. Its ten largest holdings account for 42% of the portfolio.
Its largest position is Humana: 38,160 shares worth $11.2M.
By sector, the portfolio is most concentrated in Healthcare at 68% of assets, followed by Financials and Energy.
- Persistent Asset Partners's largest Q4 2024 buy was Humana: 38,160 shares worth $11.2M.
- Persistent Asset Partners's ten largest holdings make up 42% of its $121M portfolio in Q4 2024.
- Persistent Asset Partners disclosed 143 positions in Q4 2024, its first 13F filing on record.
Based on Persistent Asset Partners's 13F filing for Q4 2024, filed 14 Feb 2025.